Chiron Discussing Fluvirin Corrective Manufacturing Plan For Liverpool Plant

Chiron expects to implement a "remediation plan" over the coming months for a Liverpool facility after meeting with British regulatory officials on the suspension of its Fluvirin manufacturing license

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Archive

More from Pink Sheet